Can Roche’s little tech startup help the FDA change clinical trials?
WILDE COMPANY
The Food and Drug Administration is open to the possibility, if a newly expanded research relationship on real world data is any indication.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario